We've got a New Contraceptive PATCH Study now enrolling: Similar to the already approved Xulane patch, but with a lower dose estrogen. Note that lower estrogen doses are associated with improved safety in other combined hormonal contraceptives.

To qualify you must:

be healthy, at least 18 years old, with regular menstrual cycles
be at risk for pregnancy by engaging in sexual intercourse at least 1x per month
want to avoid pregnancy during the entire 13 months of study
agree to use study patch contraception as the only form on birth control during the study, except emergency backup barrier contraception or emergency contraception when necessary
not have sensitivity to medicated patches or bandages, etc.
not have any known contraindication to combined hormonal contraception use and cannot use nicotine in any form if 35 years old or older

Other criteria also apply. Qualified participants receive free birth control for the entire study, free study-related exams, labs and compensation to $525. Daily diary entries are required of participants.

The Luminous Research Study is for an investigational birth control patch for women who wish to use a skin patch to prevent pregnancy. Healthy female participants of childbearing potential aged at least 16 years old who agree to be in this study will receive transdermal patches containing norelgestromin and ethinyl estradiol.

The study will enroll approximately 1,200 subjects (1,080 women aged 16 to 35 years and about 120 women over 35 years of age) at about 55 study centers across the United States. Be one of the 1200 who makes a difference in Women's Health and Contraceptive choices! Benefits: Compensation to $525, along with free contraception, free study-related medical exams, and free study-related labs.

The Luminous Research Study is for an investigational birth control patch for women who wish to use a skin patch to prevent pregnancy.

The study medication is an investigational birth control patch being developed for use by women who wish to use a skin patch to prevent pregnancy. The study patch is similar to the already approved product, Xulane^®, but contains a lower dose of estrogen. Note that lower estrogen doses are associated with improved safety in other combined hormonal contraceptives.

The birth control patch is a transdermal (applied to the skin) drug delivery system. The study medication looks like a round Band Aid and can be applied to either the skin on the upper outer arm, stomach, buttock or back, in a place where it will not be rubbed by tight clothing. The drugs contained in the patch are absorbed through the skin. All participants in the study will receive patches containing the birth control medication; there is no placebo or birth control pill being used in the study.

The patch is used in a 4-week (28-day) treatment cycle where a patch is applied and replaced every 7 days for 3 weeks in a row, followed by a 1-week “patch-free” period. Qualified participants will use the patch for up to 13 cycles (about 1 year).

Benefits: Compensation to $525, along with free contraception, free study-related medical exams, and free study-related labs.